These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 22038453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anabolic and antiresorptive therapy for osteoporosis: combination and sequential approaches.
    Cosman F.
    Curr Osteoporos Rep; 2014 Dec; 12(4):385-95. PubMed ID: 25341476
    [Abstract] [Full Text] [Related]

  • 6. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H, Sugimoto T.
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [Abstract] [Full Text] [Related]

  • 7. The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial.
    Quesada-Gómez JM, Muschitz C, Gómez-Reino J, Greisen H, Andersen HS, Dimai HP.
    Osteoporos Int; 2011 Sep; 22(9):2529-37. PubMed ID: 21052638
    [Abstract] [Full Text] [Related]

  • 8. Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS).
    Schafer AL, Burghardt AJ, Sellmeyer DE, Palermo L, Shoback DM, Majumdar S, Black DM.
    Osteoporos Int; 2013 Oct; 24(10):2591-601. PubMed ID: 23589163
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
    Reginster JY, Bruyère O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A, Devogelaer JP.
    Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women.
    Adami S.
    Curr Med Res Opin; 2008 Nov; 24(11):3259-74. PubMed ID: 18940041
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Impacts on bone mineral density].
    Kurth A.
    Orthopade; 2014 Feb; 43(2):182. PubMed ID: 24693554
    [No Abstract] [Full Text] [Related]

  • 15. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
    Uebelhart D, Frey D, Frey-Rindova P, Goerres G, Michel BA.
    Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
    [Abstract] [Full Text] [Related]

  • 16. Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.
    Krieg MA, Aubry-Rozier B, Hans D, Leslie WD, Manitoba Bone Density Program.
    Osteoporos Int; 2013 Mar; 24(3):1073-8. PubMed ID: 23052939
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.